Conference Material
|
Slide Presentation
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis
Arana B
View HTML
View PDF
Share
Download
Download
View HTML
View PDF
Share
Similar Content
Loading...
Loading...
Loading...
Countries
Colombia
Peru
Subject Area
neglected tropical diseases
cutaneous leishmaniasis
Languages
English
DOI
10.7490/f1000research.1117902.1
Published Date
13 May 2020
Conference
MSF Scientific Days International 2020
Dimensions Badge
Safety and efficacy data from a phase 2 randomized trial of a miltefosine/thermotherapy combination in uncomplicated New World cutaneous leishmaniasis | Conference Material / Slide Presentation | MSF Science Portal
